advanced search

INJECTION

BUILDING BRIDGES FROM DRUGS TO PATIENTS: USABILITY & HUMAN FACTORS
INJECTION
Nicolas Sandoz
BUILDING BRIDGES FROM DRUGS TO PATIENTS: USABILITY & HUMAN FACTORS
Nicolas Sandoz describes Sensile Medical’s approach to ensuring it takes usability and human factors into account during the development of its devices, in particular for subcutaneous delivery.
DRUG CONTAINMENT & DELIVERY INNOVATION
WEARABLES
Chris Henshall
West Pharmaceutical Services
DRUG CONTAINMENT & DELIVERY INNOVATION
Chris Henshall discusses how West's SmartDose platform considers the interface between drug, device and patient and how it offers an easy-to-use, reliable and integrated system for managing self-injection.
A COLLABORATION THAT SAYS YOU’RE IN SAFE HANDS
PREFILLED SYRINGES
Pascal Dugand
Nemera
A COLLABORATION THAT SAYS YOU’RE IN SAFE HANDS
William Dierick, Pascal Dugand and Adrien Tisserand describe a collaboration to create a compatibility between Terumo’s PLAJEX™; prefillable syringes with Nemera’s Safe‘n’Sound® platform of add-on passive sharps injury protection devices for PFS.
COMPANY SHOWCASE: AVERY DENNISON
INJECTION
COMPANY SHOWCASE: AVERY DENNISON
As labelling technology continues to develop, pharmaceutical labels are making an increasingly significant contribution to operational efficiencies, and to security and compliance. Smarter and more dependable labelling solutions are important in often safety-critical clinical environments.
SAFER PREFILLED SYRINGES & FEWER PROCESS CHANGES
PREFILLED SYRINGES
Jean Vuillecard
Biocorp
SAFER PREFILLED SYRINGES & FEWER PROCESS CHANGES
Jean Vuillecard, Philippe Lesaulnier and Eric Dessertenne explain how, despite great innovations, adopting new syringe safety systems has always been a trade-off between safety and the cost of implementing new processes and introduce Biocorp's Newguard™, a new passive safety system integrated on prefilled syringes without such compromises being required.
PRODUCT SHOWCASE: PREMIUMCOAT™
INJECTION
Anne Bailly
Aptar Pharma
PRODUCT SHOWCASE: PREMIUMCOAT™
PremiumCoat™ is a novel range of elastomeric stoppers developed by Aptar Pharma and based on an approved, pure, state-of-the-art formulation. The surface of the elastomer is coated during manufacturing with a thin fluoropolymer film.
THE ADD-ON APPROACH TO CONNECTIVITY
CONNECTIVITY
Christian Keller
SHL Medical
THE ADD-ON APPROACH TO CONNECTIVITY
William Cirillo and Christian Keller describe a simple add-on connected digital platform that can work with an existing delivery device. Digital health is an umbrella term that covers a lot of different applications of technology in the health industry. From wearable sensors and electronic health records to health apps, connected and digital solutions are becoming more accepted.
DRUGDELIVERYSYSTEM FOR 1 ML LONG PREFILLED SYRINGES
PREFILLED SYRINGES
Hans Peter Manser
DRUGDELIVERYSYSTEM FOR 1 ML LONG PREFILLED SYRINGES
Ludwig Weibel and Hans Peter Manser ask, how can drug delivery systems help in patient compliance? And what are the challenges to be encountered with novel drugs filled in 1 mL long prefilled syringes? A novel and innovative approach is presented meeting the requirements of today’s and future drug applications.
PACKAGING & MACHINERY ENGINEERED TO GO HAND-IN-HAND
INJECTION
Christoph Hammer
PACKAGING & MACHINERY ENGINEERED TO GO HAND-IN-HAND
Christoph Hammer explains how Dividella exclusively manufactures machines for packaging pharmaceutical products at its facility in Grabs, Switzerland. The focus is totally on the packaging of parenteral pharmaceuticals in Top-Load boxes. These sensitive products demand well thought-out packaging solutions.
ADAPTIQ<sup>®</sup> & VIALS DC
INJECTION
SCHOTT Pharma
ADAPTIQ® & VIALS DC
SCHOTT has expanded its adaptiQ® portfolio of ready-to-use pharma containers to meet growing market demand from drug manufacturers and, separately, a new series of studies has once again demonstrated the effectiveness of SCHOTT Vials Delamination Controlled (Vials DC).
MORE PRODUCT EFFICIENCY BY FULLY AUTOMATED PRODUCTION PROCESSES
INJECTION
Berthold Schopferer
MORE PRODUCT EFFICIENCY BY FULLY AUTOMATED PRODUCTION PROCESSES
Harry Pruner, Freelance Journalist, Pruner Marketing Services, gives a run-down of the machines and production lines manufactured by ZAHORANSKY for the production of ready-to-fill, prefillable syringes.
PATIENT-CENTRICITY & CONFIDENCE IN DEVICE DESIGN
PREFILLED SYRINGES
Alex Fong
Owen Mumford
PATIENT-CENTRICITY & CONFIDENCE IN DEVICE DESIGN
Alex Fong provides an overview and update on needlestick injury, its prevention and the market for needle safety devices, and introduces Unisafe™, Owen Mumford's springless, passive safety device designed to work with existing prefillable syringes.
SPRING DEVELOPMENT FOR MEDICAL DEVICES
EXPERT VIEW
Neil Fletcher
SPRING DEVELOPMENT FOR MEDICAL DEVICES
Neil Fletcher provides a spring manufacturer’s perspective of how springs can be used in medical devices, and how a lengthy and extensive device development process affects normal custom and practice in our industry. The report focuses on spring technology and highlights some of the challenges that spring manufacturers face daily.
TRANSFORMING A PROVEN AUTOINJECTOR INTO A FULLY CONNECTED DEVICE
PREFILLED SYRINGES
Orfeo Niedermann
Ypsomed
TRANSFORMING A PROVEN AUTOINJECTOR INTO A FULLY CONNECTED DEVICE
Orfeo Niedermann provides insights into how connectivity enhances existing autoinjectors and adds value for users, physicians, pharma companies and insurers.
THE DEVELOPMENT OF THE MOLLY<sup>®</sup> PLATFORM
PREFILLED SYRINGES
SHL Medical
THE DEVELOPMENT OF THE MOLLY® PLATFORM
SHL Group explores the growth of the Molly® family of drug delivery devices as an example of how the auto injector market has changed over the last five years, and looks to the future.
NOVEL APPROACHES INCREASE PATIENT CONFIDENCE & DECREASE ANXIETY
PREFILLED SYRINGES
Joe Reynolds
Noble
NOVEL APPROACHES INCREASE PATIENT CONFIDENCE & DECREASE ANXIETY
Joe Reynolds introduces the latest approaches and technologies – such as needle simulators – to equip patients for confident, anxiety-free self administration of parenteral drugs.
RISK MITIGATION, PERFORMANCE & LARGER VOLUMES DRIVE INNOVATION
PREFILLED SYRINGES
Christa Janssen-Otten
West Pharmaceutical Services
RISK MITIGATION, PERFORMANCE & LARGER VOLUMES DRIVE INNOVATION
With a focus on the company’s Novapure® brand, Christa Janssen-Otten discusses the application of quality-by-design principles in the development of plungers for prefillable syringes and autoinjectors.
COMPANY SHOWCASE: NEMERA (INJECTABLES OFFERING)
PREFILLED SYRINGES
Adrien Tisserand
Nemera
COMPANY SHOWCASE: NEMERA (INJECTABLES OFFERING)
Nemera and its partners empower patients through good design with Nemera’s extensive experience in developing and manufacturing parenteral drug delivery devices. Its global centre of expertise comprises more than 60 engineers and experts in creative design and human factors activities.
A RISK MANAGEMENT APPROACH TO PREFILLED SYRINGE SELECTION FOR BIOTECHNOLOGY PRODUCTS
PREFILLED SYRINGES
Wendy Saffell-Clemmer
A RISK MANAGEMENT APPROACH TO PREFILLED SYRINGE SELECTION FOR BIOTECHNOLOGY PRODUCTS
Prefilled syringes are becoming an increasingly attractive option for complex biotechnology products, not least because of the savings in product volume compared to vials. There is now a wide range of options to suit different requirements which can make product selection a challenge. Wendy looks at what advances are currently being made.
LUBRICIOUS COATINGS TO REDUCE SILICONE OIL & PARTICLE LEVELS
PREFILLED SYRINGES
Bernd Zeiss
Gerresheimer
LUBRICIOUS COATINGS TO REDUCE SILICONE OIL & PARTICLE LEVELS
The market for prefilled syringes continues to grow as does the number of approved biologics delivered in this manner. Bernd Zeiss and Susan Dounce outline the results of a study using the combination of a Gx Baked-on RTF® syringe and the OmniflexCP® plunger.
ADDING COLOUR & FUNCTIONALITY TO PLASTICS USED IN MEDICAL DEVICES
EXPERT VIEW
Stephen Duckworth
ADDING COLOUR & FUNCTIONALITY TO PLASTICS USED IN MEDICAL DEVICES
Stephen Duckworth explains how – with an emphasis on the importance of complying with stringent and changing pharmaceutical regulations – advanced additives in plastics used to make drug delivery devices can significantly enhance the product.
PRODUCT SHOWCASE: SCHOTT’s SYRIQ<sup>®</sup> AND TOPPAC<sup>®</sup> RIGID CAPS
PREFILLED SYRINGES
Dr Folker Steden
SCHOTT Pharma
PRODUCT SHOWCASE: SCHOTT’s SYRIQ® AND TOPPAC® RIGID CAPS
Schott has added new closure systems to its already extensive portfolio of prefillable syringes. Offering more flexibility for pharma companies while keeping patients safe.
OPTIMUM PRIMARY PACKAGING STRATEGY: EARLY & HOLISTIC DEFINITION
PREFILLED SYRINGES
Dr Kate Hudson-Farmer
OPTIMUM PRIMARY PACKAGING STRATEGY: EARLY & HOLISTIC DEFINITION
Kate Hudson-Farmer and Niels Kure reveal conflicting pressures on the product development process in orphan indications which potentially lead to products in this category – especially emerging biotech products – being left with suboptimal drug delivery systems and primary packaging.
STERILISATION EFFECTS ON BIOPHARMACEUTICALS
PREFILLED SYRINGES
William Dierick
Terumo Medical Care Solutions
STERILISATION EFFECTS ON BIOPHARMACEUTICALS
William Dierick and Koji Nakamura report studies comparing the effects of different sterilisation on the extractables and leachables content of biotherapeutic products in prefilled syringes.
Top